KP ENERGY LTD.,
Introduction:
Introducing KPI Green Energy Limited, the radiant force in sustainable energy solutions. Formerly known as KPI Global Infrastructure Limited, our journey began in February 2008, as a pivotal player in Gujarat’s solar and hybrid power landscape. As the solar and hybrid vertical of KP Group, we stand as a beacon of innovation and commitment to green energy. Our core mission is to develop, construct, and manage solar and hybrid power plants, serving as both an Independent Power Producer (IPP) and a trusted service provider to Captive Power Producers (CPP). Under the esteemed banner of ‘Solarism’, we illuminate the path towards a brighter, greener future.
|
Announcement Date
|
Ex-Date |
Dividend
|
||
|
Type |
% |
Rs |
||
|
31-10-2023 |
17-11-2023 |
Interim |
4 |
0.20 |
|
04-08-2023 |
21-08-2023 |
Interim |
5 |
0.25 |
RAM RATNA WIRES LTD
Introduction :
In the annals of our history, Ram Ratna Wires Ltd. emerges as a testament to evolution and resilience. Born as Ram Ratna Winding Wires Pvt. Limited on the 21st of July, 1992, our journey of transformation began. With the winds of change, we transitioned from a Private Limited entity to a Public Limited one, alongside a profound metamorphosis in nomenclature, becoming Ram Ratna Wires Ltd. This pivotal transition was enshrined through a Special Resolution on the 18th of November, 1992, marking a milestone in our narrative. With a fresh certificate of incorporation bestowed upon us by the Registrar of Companies, Maharashtra, Bombay, we embarked on a trajectory of growth, innovation, and unwavering commitment to excellence.
|
Announcement Date
|
Ex-Date |
Dividend
|
||
| Type | % |
Rs |
||
|
27-10-2023 |
17-11-2023 |
Interim |
0 |
0.00 |
|
27-10-2023 |
17-11-2023 |
Special |
50 |
2.50 |
APOLLO HOSPITALS
Introduction :
In the tapestry of India’s healthcare landscape, a pioneering vision took root in 1983, sowing the seeds of transformative care. Founded by the visionary Prathap C. Reddy, our journey began as a beacon of corporate healthcare innovation, heralding a new era of medical excellence. Apollo, synonymous with quality and compassion, stands as the vanguard of healthcare evolution. Our commitment to international standards of care is exemplified by numerous accolades, including accreditation by the prestigious Joint Commission International (JCI) and the National Accreditation Board for Hospitals & Healthcare Providers (NABH). As trailblazers in healthcare, Apollo continues to redefine standards, shaping a healthier, brighter future for all.
|
Announcement Date
|
Ex-Date |
Dividend
|
||
| Type | % |
Rs |
||
|
30-05-2023 |
18-08-2023 |
Final |
120 |
6.00 |
|
14-02-2023 |
17-11-2023 |
Final |
180 |
9.00 |
CASTROL INDIA
Introduction :
A legacy forged in the crucible of innovation, Castrol India embarked on its illustrious journey in 1910, introducing automotive lubricants sourced from C C Wakefield & Company to the burgeoning Indian market. The dawn of a new era arrived in 1979 with the inception of CIL, born as Indrol Lubricants and Specialities Pvt Ltd. This pivotal moment marked the genesis of a company destined for greatness. By 1982, CIL stepped onto the public stage, gracing the floors of the Bombay Stock Exchange (BSE) and assuming the mantle of a public limited entity. The horizon of opportunity expanded further in 1987 with the establishment of Indtech Speciality Chemicals Ltd., a testament to our unwavering commitment to diversification and excellence. Through every chapter of our storied history, Castrol India continues to drive forward, lubricating the wheels of progress with innovation, integrity, and dedication.
|
Announcement Date
|
Ex-Date |
Dividend
|
||
|
Type |
% |
Rs |
||
|
03-07-2023 |
21-03-2024 |
Final |
90 |
4.50 |
|
13-02-2023 |
08-08-2023 |
Interim |
60 |
3.00 |
BIOCON
Introduction:
Nurtured from a vision of scientific advancement, Biocon Limited stands as a beacon of innovation in the Indian biopharmaceutical landscape. Founded in 1978 by the pioneering spirit of Kiran Mazumdar-Shaw, our journey began in the vibrant city of Bangalore. With a global footprint spanning approximately 120 countries, including the esteemed markets of the United States and Europe, we are committed to delivering excellence in healthcare. At the heart of our operations lies the manufacturing of generic active pharmaceutical ingredients (APIs), enriching lives across diverse demographics. Yet, our ambitions soar beyond convention, as we craft novel biologics and pioneer biosimilar insulins and antibodies.
|
Announcement Date
|
Ex-Date |
Dividend
|
||
| Type | % |
Rs |
||
|
24-05-2023 |
07-07-2023 |
Final |
30 |
1.50 |
|
28-04-2022 |
07-07-2023 |
Final |
10 |
0.50 |
